$ONMD

Kosasa Thomas purchased $100K of ONMD

Kosasa Thomas purchased 158,730 shares of OneMedNet Corp (ONMD) at $0.63 on 2026-06-12.

Original reporting
SEC EDGAR · Kosasa Thomas
Published Jun 15, 2026, 10:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 10:27 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ONMD
Bullish
medium confidence
Mentioned
$ONMD
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ONMDBullishLow
01

Why it matters

The newest information is the specific open-market purchase size, price, and post-transaction holdings by a director/10% owner.

02

Market read

Traders may treat the filing as a sentiment input, but it does not replace fundamental catalysts.

03

What to watch

The article notes no pre-arranged 10b5-1 plan, but it still lacks context on prior trading history, size vs typical activity, and whether the purchase was funded by existing holdings.

Relevance 4/10Novelty 8/10Timing: Filed 2026-06-15 (transaction dated 2026-06-12)

Background

The article is an SEC Form 4 insider transaction disclosure for OneMedNet Corp (ONMD).

Company-level read

Ticker impact

$ONMDBullishMedium confidence
Context

SEC Form 4 shows director/10% owner Kosasa Thomas bought 158,730 shares of OneMedNet at $0.6300 on 2026-06-12.

Expected impact

Likely limited near-term impact; may modestly support sentiment in thin-liquidity trading.

Evidence & confidence

The filing is primary-source and the buyer is a director/10% owner, but the article provides no new operating/financial information beyond the transaction details.

Market effects

No sector-level read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine (e.g., liquidity needs or diversification) and may not reflect near-term business improvement.

Key entities

  • OneMedNet Corp

    Subject of the SEC Form 4 insider transaction disclosure.

  • Kosasa Thomas

    Director and 10% owner who reported an open-market purchase.

Related articles